Related Experiment Video
Updated: Feb 10, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR qPCR
Published on: May 16, 2012
MicroRNAs as potential therapeutics to enhance chemosensitivity in advanced prostate cancer
Hui-Ming Lin1,2, Iva Nikolic1,2,3, Jessica Yang1
1Cancer Division, The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst, New South Wales, 2010, Australia.
Abstract:
Docetaxel and cabazitaxel are taxane chemotherapy treatments for metastatic castration-resistant prostate cancer (CRPC). However, therapeutic resistance remains a major issue. MicroRNAs are short non-coding RNAs that can silence multiple genes, regulating several signalling pathways simultaneously. Therefore, synthetic microRNAs may have therapeutic potential in CRPC by regulating genes involved in taxane response and minimise compensatory mechanisms that cause taxane resistance. To identify microRNAs that can improve the efficacy of taxanes in CRPC, we performed a genome-wide screen of 1280 microRNAs in the CRPC cell lines PC3 and DU145 in combination with docetaxel or cabazitaxel treatment. Mimics of miR-217 and miR-181b-5p enhanced apoptosis significantly in PC3 cells in the presence of these taxanes. These mimics downregulated at least a thousand different transcripts, which were enriched for genes with cell proliferation and focal adhesion functions. Individual knockdown of a selection of 46 genes representing these transcripts resulted in toxic or taxane sensitisation effects, indicating that these genes may be mediating the effects of the microRNA mimics. A range of these genes are expressed in CRPC metastases, suggesting that these microRNA mimics may be functional in CRPC. With further development, these microRNA mimics may have therapeutic potential to improve taxane response in CRPC patients.
Insights
Synthetic microRNAs, miR-217 and miR-181b-5p, show promise in enhancing taxane chemotherapy for metastatic castration-resistant prostate cancer (CRPC). These microRNAs may overcome therapeutic resistance by downregulating key cancer-related genes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Metastatic castration-resistant prostate cancer (CRPC) poses significant treatment challenges, with therapeutic resistance to taxane chemotherapy (docetaxel, cabazitaxel) being a major clinical issue.
- MicroRNAs (miRNAs) are key regulators of gene expression, offering potential therapeutic avenues by targeting multiple signaling pathways simultaneously.
- Understanding miRNA roles in taxane resistance is crucial for developing novel treatment strategies in CRPC.
Purpose of the Study:
- To identify specific microRNAs capable of enhancing the efficacy of taxane-based chemotherapy in CRPC.
- To investigate the potential of synthetic microRNAs as a therapeutic approach to overcome taxane resistance in CRPC.
Main Methods:
- A genome-wide screen of 1280 microRNAs was conducted in PC3 and DU145 CRPC cell lines treated with docetaxel or cabazitaxel.
- The impact of miRNA mimics on apoptosis and gene expression was assessed.
- Individual knockdown of selected target genes was performed to validate their role in miRNA-mediated taxane sensitization.
Main Results:
- Mimics of miR-217 and miR-181b-5p significantly enhanced apoptosis in PC3 cells when combined with taxanes.
- These miRNA mimics downregulated over a thousand transcripts, notably those involved in cell proliferation and focal adhesion.
- Knockdown of selected target genes confirmed their involvement in mediating the taxane-sensitizing effects of the miRNA mimics.
Conclusions:
- miR-217 and miR-181b-5p hold therapeutic potential for improving taxane response in CRPC by targeting genes regulating cell proliferation and adhesion.
- These miRNA mimics may represent a novel strategy to overcome therapeutic resistance in CRPC patients.
- Further development of these miRNA mimics could lead to improved treatment outcomes for CRPC.
Related Concept Videos
MicroRNAs
MicroRNAs
Therapeutic Index
Overview of Advanced Functional Groups
Functional groups are groups of atoms with specific chemical properties that occur within organic molecules and are sometimes denoted as “R”. Functional groups can “functionalize” a compound by enabling it to adopt different physical and chemical properties.
Types of Advanced Functional Groups
The table below summarizes some of the major functional groups in organic chemistry.
Potential Energy
Chemical bonds that form attractive forces between atoms also contain potential energy, called chemical energy. When a chemical reaction...
Self-Evaluation: Self-Enhancement and Self-Verification

